High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$149K
$149,912
Total Sells (Filtered)
$3.9M
$3,932,173
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VKTX
P
Viking Therapeutics, Inc.
Aubuchon Neil William
• Officer • Chief Commercial Officer
Discretionary Buy
2026-03-10
$149,912
|
||||||
| VKTX |
Viking Therapeutics, Inc.
|
Officer • Chief Commercial Officer
Discretionary Buy
|
2026-03-10 | $149,912 | P | Form 4 |
| VKTX |
Viking Therapeutics, Inc.
|
CFO
Sell to Cover
|
2025-10-28 | $216,481 | S | Form 4 |
| VKTX |
Viking Therapeutics, Inc.
|
CEO
Sell to Cover
|
2025-10-28 | $1,364,923Large | S | Form 4 |
| VKTX |
Viking Therapeutics, Inc.
|
COO
Sell to Cover
|
2025-10-28 | $216,492 | S | Form 4 |
|
VKTX
S
Viking Therapeutics, Inc.
Rowland Charles A Jr
• Director
Discretionary SellΔOwn -66.7%
2025-10-27
$2,134,278Large
|
||||||
| VKTX |
Viking Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -66.7%
|
2025-10-27 | $2,134,278Large | S | Form 4 |